Source: PLOS ONE. Unidades: FMVZ, FZEA, ICB
Subjects: ATROFIA MUSCULAR, CÃES, DISTROFIA MUSCULAR ANIMAL, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAÚJO, Karla Patrícia Cardoso et al. Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin- glycoprotein complex in GRMD dogs. PLOS ONE, v. 8, n. 4, 2013Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0061367. Acesso em: 25 maio 2024.APA
Araújo, K. P. C., Bonuccelli, G., Duarte, C. N., Gaiad, T. P., Moreira, D. F., Feder, D., et al. (2013). Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin- glycoprotein complex in GRMD dogs. PLOS ONE, 8( 4). doi:10.1371/journal.pone.0061367NLM
Araújo KPC, Bonuccelli G, Duarte CN, Gaiad TP, Moreira DF, Feder D, Belizário JE, Miglino MA, Lisanti MP, Ambrósio CE. Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin- glycoprotein complex in GRMD dogs [Internet]. PLOS ONE. 2013 ; 8( 4):[citado 2024 maio 25 ] Available from: https://doi.org/10.1371/journal.pone.0061367Vancouver
Araújo KPC, Bonuccelli G, Duarte CN, Gaiad TP, Moreira DF, Feder D, Belizário JE, Miglino MA, Lisanti MP, Ambrósio CE. Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin- glycoprotein complex in GRMD dogs [Internet]. PLOS ONE. 2013 ; 8( 4):[citado 2024 maio 25 ] Available from: https://doi.org/10.1371/journal.pone.0061367
